PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
350.00%
Some net income increase while MRVL is negative at -0.22%. John Neff would see a short-term edge over the struggling competitor.
-1.41%
Negative yoy D&A while MRVL is 0.58%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
-152.94%
Negative yoy deferred tax while MRVL stands at 0.00%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
No Data
No Data available this quarter, please select a different quarter.
-25.20%
Both reduce yoy usage, with MRVL at -79.34%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
No Data
No Data available this quarter, please select a different quarter.
-205.88%
Both reduce yoy inventory, with MRVL at -107.11%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
No Data
No Data available this quarter, please select a different quarter.
2.73%
Lower 'other working capital' growth vs. MRVL's 129.18%. David Dodd would see fewer unexpected short-term demands on cash.
115.79%
Growth of 115.79% while MRVL is zero at 0.00%. Bruce Berkowitz would see a moderate difference that might reflect intangible expansions or partial write-offs.
30.74%
Some CFO growth while MRVL is negative at -19.13%. John Neff would note a short-term liquidity lead over the competitor.
-47.50%
Negative yoy CapEx while MRVL is 63.62%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
No Data
No Data available this quarter, please select a different quarter.
11.20%
Less growth in investment purchases vs. MRVL's 87.07%, preserving near-term liquidity. David Dodd would confirm no strategic investment opportunities are lost.
35.70%
We have some liquidation growth while MRVL is negative at -81.97%. John Neff notes a short-term liquidity advantage if competitor is holding or restricted.
No Data
No Data available this quarter, please select a different quarter.
67.90%
Investing outflow well above MRVL's 88.80%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
No Data
No Data available this quarter, please select a different quarter.
183.33%
Lower share issuance yoy vs. MRVL's 729.12%, implying less dilution. David Dodd would confirm the firm still has enough capital for expansions.
-138.10%
We cut yoy buybacks while MRVL is 97.25%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.